Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021
CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.
- CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain totreatneurosciencediseases, today announced it will report second quarter 2021 financial results and provide a pipeline update on Wednesday, August 11, 2021, before the U.S. financial markets open.
- Management will host a conference call to discuss second quarter 2021 financial results and recent business and pipeline updates on Wednesday, August 11, 2021 at 8:00 a.m. EDT.
- Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases.
- Forward-looking statements in this press release include, but are not limited to, statements about the timing of reporting of our second quarter 2021 financial results and the potential attributes and benefits of our product candidates.